CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 31 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-12 | Abingworth LLP Former 10% Owner | Conversion | +126,645 | $0.99 | $126K | 2,144,517 |
| 2019-11-12 | Abingworth LLP Former 10% Owner | Conversion · Series A Convertible Preferred Stock | −126 | 2,400 | ||
| 2018-06-08 | Abingworth LLP 10% owner | Grant or award · Stock Option (Right to Buy) | +12,700 | 12,700 | ||
| 2017-06-22 | Abingworth LLP 10% owner | Purchase · Series A Convertible Preferred Stock | +2,526 | $1,000.00 | $2.5M | 2,526 |
| 2017-06-20 | Abingworth LLP 10% owner | Grant or award · Stock Option (Right to Buy) | +6,666 | 6,666 | ||
| 2016-06-09 | Abingworth LLP 10% owner | Grant or award · Stock Option (Right to Buy) | +6,666 | 6,666 |
Page 1 of 1 · 6 trades